An update of recent clinical trials examining adapalene and acne

Journal of the European Academy of Dermatology and Venereology

Volumn 15, Issue SUPPL. 3, 2001, Pages 23-29

  Wolf, J E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acne vulgaris; Adapalene; Clinical trials

Indexed keywords

ADAPALENE; AKNE MYCIN PLUS; BENZAMYCIN; BENZOYL PEROXIDE; CLINDAMYCIN; ERYLIK; ERYTHROMYCIN; ISOTREXIN; MICROSPHERE; PETROLATUM; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOL; TAZAROTENE;

ACNE VULGARIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; HUMAN; PRIORITY JOURNAL; SKIN IRRITATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CONTROLLED CLINICAL TRIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NAPHTHALENES; PROBABILITY; TREATMENT OUTCOME; TRETINOIN;

EID: 0035674049     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0926-9959.2001.00009.x     Document Type: Article

References (17)

1. Dispelling myths about acne
2. Adapalene for the treatment of acne vulgaris
3. New treatments and therapeutic strategies for acne
4. The in vivo and in vitro anti-inflammatory activity of CD 271, a new retinoid-like modulator of cell differentiation
5. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial
6. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials
7. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris
8. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients
9. Adapalene 0.1% gel has low skin-irritation potential
10. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR
11. Effect of polyolprepolymer on the disposition of retinoic acid in various strata of hamster ear following topical in vivo application of gel formulations: Correlation with disposition in human skin
12. Comparative efficacy and safety of two 0.025% tretinoin gels: Results from a multicenter double-blind, parallel study
13. Irritation potential of Avita, a new topical tretinoin formulation, and Retin-A as measured by patch testing in human subjects
14. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life
15. Adapalene 0.1% gel for the treatment of acne vulgaris: Its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference
16. Comparison of the cumulative irritation potential of adapalene gel and adapalene solution (0.1%) with tazarotene gel and several tretinoin formulations
17. Skin tolerance of adapalene 0.1% gel in combination with other topical anti-acne treatments